Therefore, this study aims to comprehensively investigate NOD2’s functional role in GBM progression through a systematic analysis of its effects on proliferation, migration, and invasion and its potential influence on EMT and CSC markers, with the ultimate goal of establishing NOD2 as a potential therapeutic target for GBM treatment. The gene discussed is NOD2; the disease is glioblastoma.